Developmental Research Program
- Institution
- DANA-FARBER CANCER INST, MA
- Principal investigator
- Matthew L Freedman
- Funding
- $209K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY The objective of the SPORE Developmental Research Program (DRP) is to identify and support exciting prostate cancer research and ensure a continuous renewal of high-quality scientific endeavors within the SPORE. The program will recruit across multiple disciplines and backgrounds to bring fresh ideas and new approaches to prostate cancer. Applications will be solicited broadly and reviewed fairly by a highly qualified and engaged committee. DRP recipients will become part of the SPORE community with exposure, feedback, and access to core resources. Progress will be monitored, and recipients will be helped and encouraged to apply for other funding opportunities. Overall, the DRP will maximize the chance that new and cutting-edge concepts supported by promising pilot data have the capability to receive larger grant funding and ultimately impact the field. This will be achieved through the following specific aims: 1) Foster the development of innovative and promising prostate cancer research by providing seed funding to the highest rated projects solicited from RFAs; 2) Identify and prioritize solicitations focused on areas of with the potential to have the highest impact of improving the outcome of patients with prostate cancer; 3) Monitor the progress of developmental projects, provide critical and timely feedback, and encourage and enable promising DRP projects to compete for extramural peer-reviewed funding. When necessary and promising, promote the most meritorious DRP projects to full SPORE research projects; 4) Bring new investigators into prostate cancer translational research.
LOADING MOONBASE SCORE
Questions for DANA-FARBER CANCER INST
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Dana-Farber Cancer InstNot yet scored
Mapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell epigenomics for early detection of lineage plasticity and clinical decision-making
Andre Bergman · $627K · 2025–2030
- NIH · Dana-Farber Cancer InstNot yet scored
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies
Matthew L Freedman · $1.3M · 2022–2027
- NIH · Dana-Farber Cancer InstNot yet scored
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
Matthew L Freedman · $675K · 2021–2026